Current Drug Targets
Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Drug Targets, Volume 15 - Number 14
Editorial
Editorial: New Strategies and Applications for Drugs Targeting EGFR and c-Met
, 15(14): 1261 - 1262E. Giovannetti and L.G. Leon
DOI: 10.2174/1389450115666141107104844
Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer
, 15(14): 1263 - 1272Shigehiro Yagishita and Akinobu Hamada
DOI: 10.2174/1389450115666141110154838
Epidermal Growth Factor Receptor Targeting in Non-Small Cell Lung Cancer: Revisiting Different Strategies Against the Same Target
, 15(14): 1273 - 1283Eduardo Castanon, Patricia Martin, Christian Rolfo, Juan P. Fusco, Lucia Ceniceros, Jairo Legaspi, Marta Santisteban and Ignacio Gil-Bazo
DOI: 10.2174/138945011514141216092935
The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?
, 15(14): 1284 - 1292Francesco Passiglia, Nele Van Der Steen, Luis Raez, Patrick Pauwels, Ignacio Gil-Bazo, Edgardo Santos, Daniele Santini, Giovanni Tesoriere, Antonio Russo, Giuseppe Bronte, Karen Zwaenepoel, Federico Cappuzzo and Christian Rolfo
DOI: 10.2174/138945011514141216092739
EGFR as a Potential Target for the Treatment of Pancreatic Cancer: Dilemma and Controversies
, 15(14): 1293 - 1301Reza Nedaeinia, Amir Avan, Mostafa Manian, Rasoul Salehi and Majid Ghayour-Mobarhan
DOI: 10.2174/1389450115666141125123003
Targeting c-MET/HGF Signaling Pathway in Upper Gastrointestinal Cancers: Rationale and Progress
, 15(14): 1302 - 1311Sharareh Gholamin, Hamid Fiuji, Mina Maftouh, Reza Mirhafez, Fatemeh Homaei Shandiz and Amir Avan
DOI: 10.2174/1389450115666141107105456
Modulation of Signaling Enhances the Efficacy of the Combination of Satraplatin and Erlotinib
, 15(14): 1312 - 1321Abolfazl Avan, Auke D. Adema, Eveline K. Hoebe, Charlotte M. Huijts, Amir Avan, Gareth J. Veal, Rob Ruijtenbeek, Katja Wosikowski and Godefridus J. Peters
DOI: 10.2174/1389450115666141107110321
The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib
, 15(14): 1322 - 1330Letizia Porcelli, Elisa Giovannetti, Yehuda G. Assaraf, Gerrit Jansen, George L. Scheffer, Ietje Kathman, Amalia Azzariti, Angelo Paradiso and Godefridus J. Peters
DOI: 10.2174/1389450116666141205145620
Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells
, 15(14): 1331 - 1340Leticia G. Leon, Maria Gemelli, Rocco Sciarrillo, Amir Avan, Niccola Funel and Elisa Giovannetti
DOI: 10.2174/1389450116666141205160924
The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy
, 15(14): 1341 - 1353Fiona H. Tan, Tracy L. Putoczki, Stanley S. Stylli and Rodney B. Luwor
DOI: 10.2174/1389450115666141120104146
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Webmaster Contact: info@benthamscience.net